Paula Emanuela Voinescu, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Epilepsy | 11 | 2024 | 3301 | 1.860 |
Why?
|
| Anticonvulsants | 9 | 2024 | 1914 | 1.220 |
Why?
|
| Epilepsy, Reflex | 1 | 2023 | 26 | 0.900 |
Why?
|
| Epilepsy, Frontal Lobe | 1 | 2021 | 26 | 0.830 |
Why?
|
| Pregnanolone | 1 | 2021 | 62 | 0.770 |
Why?
|
| Menstrual Cycle | 1 | 2023 | 551 | 0.710 |
Why?
|
| Seizures | 10 | 2024 | 2851 | 0.700 |
Why?
|
| Pregnancy Complications | 3 | 2018 | 2861 | 0.670 |
Why?
|
| Epilepsies, Partial | 1 | 2021 | 436 | 0.610 |
Why?
|
| Menstruation Disturbances | 1 | 2017 | 148 | 0.570 |
Why?
|
| Pregnant Women | 1 | 2021 | 566 | 0.560 |
Why?
|
| Folic Acid | 1 | 2023 | 1300 | 0.550 |
Why?
|
| Vagus Nerve | 1 | 2017 | 437 | 0.510 |
Why?
|
| Amacrine Cells | 3 | 2014 | 53 | 0.490 |
Why?
|
| Contraception | 1 | 2017 | 356 | 0.480 |
Why?
|
| Electric Stimulation Therapy | 1 | 2017 | 605 | 0.400 |
Why?
|
| Postpartum Period | 4 | 2022 | 1078 | 0.400 |
Why?
|
| Breast Feeding | 2 | 2023 | 1339 | 0.380 |
Why?
|
| Pregnancy | 12 | 2024 | 29087 | 0.370 |
Why?
|
| Dietary Supplements | 1 | 2023 | 3294 | 0.370 |
Why?
|
| Menopause | 1 | 2017 | 1621 | 0.350 |
Why?
|
| Neurogenesis | 1 | 2009 | 829 | 0.220 |
Why?
|
| Retina | 2 | 2011 | 2611 | 0.210 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2024 | 2407 | 0.190 |
Why?
|
| Neurosciences | 1 | 2024 | 347 | 0.170 |
Why?
|
| Progesterone | 1 | 2023 | 773 | 0.170 |
Why?
|
| Syncope | 1 | 2022 | 429 | 0.160 |
Why?
|
| Depression, Postpartum | 1 | 2022 | 339 | 0.150 |
Why?
|
| Pregnancy Trimesters | 1 | 2018 | 192 | 0.150 |
Why?
|
| Rod Cell Outer Segment | 1 | 2014 | 56 | 0.120 |
Why?
|
| Electroencephalography | 2 | 2022 | 6142 | 0.120 |
Why?
|
| Female | 16 | 2024 | 379592 | 0.120 |
Why?
|
| Humans | 19 | 2024 | 742088 | 0.120 |
Why?
|
| Prospective Studies | 6 | 2024 | 53187 | 0.110 |
Why?
|
| Cell Differentiation | 1 | 2009 | 11470 | 0.110 |
Why?
|
| Patient Selection | 1 | 2024 | 4214 | 0.100 |
Why?
|
| Multipotent Stem Cells | 1 | 2012 | 183 | 0.100 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2014 | 608 | 0.100 |
Why?
|
| Retinal Ganglion Cells | 2 | 2014 | 771 | 0.090 |
Why?
|
| Glycine | 2 | 2011 | 671 | 0.090 |
Why?
|
| Radiation Injuries | 1 | 2016 | 1178 | 0.080 |
Why?
|
| Biomedical Research | 1 | 2024 | 3306 | 0.080 |
Why?
|
| Quality Improvement | 1 | 2022 | 3738 | 0.070 |
Why?
|
| gamma-Aminobutyric Acid | 2 | 2011 | 1123 | 0.070 |
Why?
|
| Diagnosis, Differential | 1 | 2022 | 12958 | 0.070 |
Why?
|
| Cerebrovascular Circulation | 1 | 2016 | 2732 | 0.070 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2011 | 1114 | 0.060 |
Why?
|
| Depressive Disorder, Major | 1 | 2022 | 4628 | 0.060 |
Why?
|
| Migraine Disorders | 1 | 2016 | 1620 | 0.060 |
Why?
|
| Child | 4 | 2024 | 77478 | 0.060 |
Why?
|
| Control Groups | 1 | 2022 | 105 | 0.050 |
Why?
|
| Neurons | 1 | 2021 | 9325 | 0.050 |
Why?
|
| Pregnancy, Unplanned | 1 | 2022 | 95 | 0.050 |
Why?
|
| Risk Assessment | 1 | 2023 | 23320 | 0.050 |
Why?
|
| Cohort Studies | 4 | 2023 | 40450 | 0.050 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2011 | 3617 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2011 | 4465 | 0.040 |
Why?
|
| Animals | 5 | 2021 | 168561 | 0.040 |
Why?
|
| Young Adult | 2 | 2023 | 56350 | 0.040 |
Why?
|
| Aging | 1 | 2014 | 8626 | 0.030 |
Why?
|
| Adolescent | 2 | 2023 | 85649 | 0.030 |
Why?
|
| Retinal Bipolar Cells | 1 | 2014 | 47 | 0.030 |
Why?
|
| Male | 6 | 2024 | 349538 | 0.030 |
Why?
|
| Stroke | 1 | 2016 | 9963 | 0.030 |
Why?
|
| Mothers | 1 | 2023 | 2163 | 0.030 |
Why?
|
| Electroretinography | 1 | 2014 | 509 | 0.030 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2022 | 6030 | 0.030 |
Why?
|
| Glycine Plasma Membrane Transport Proteins | 1 | 2011 | 21 | 0.030 |
Why?
|
| Shiga Toxin 1 | 1 | 2011 | 42 | 0.030 |
Why?
|
| Adult | 3 | 2023 | 213712 | 0.030 |
Why?
|
| Matrix Attachment Region Binding Proteins | 1 | 2011 | 44 | 0.020 |
Why?
|
| Bromodeoxyuridine | 1 | 2011 | 322 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 3 | 2014 | 21821 | 0.020 |
Why?
|
| Glutamate Decarboxylase | 1 | 2011 | 246 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2014 | 1802 | 0.020 |
Why?
|
| Macaca | 1 | 2011 | 440 | 0.020 |
Why?
|
| Electroporation | 1 | 2011 | 251 | 0.020 |
Why?
|
| Mice | 3 | 2012 | 81045 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2012 | 1950 | 0.020 |
Why?
|
| Luminescent Proteins | 1 | 2011 | 853 | 0.020 |
Why?
|
| Time Factors | 1 | 2009 | 40054 | 0.020 |
Why?
|
| Cognition | 1 | 2023 | 6722 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2011 | 2723 | 0.020 |
Why?
|
| Electronic Health Records | 1 | 2022 | 4440 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2011 | 1692 | 0.020 |
Why?
|
| Synapses | 1 | 2014 | 1724 | 0.020 |
Why?
|
| Critical Care | 1 | 2017 | 2640 | 0.010 |
Why?
|
| Cell Lineage | 1 | 2012 | 2504 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2014 | 8436 | 0.010 |
Why?
|
| Depression | 1 | 2022 | 7733 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2017 | 14720 | 0.010 |
Why?
|
| Middle Aged | 3 | 2023 | 213127 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2023 | 40955 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2017 | 7276 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2014 | 14554 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2011 | 9735 | 0.010 |
Why?
|
| Aged | 2 | 2017 | 162944 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2011 | 12164 | 0.010 |
Why?
|